Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 453-458, May 2006

Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination

  • Peter Laverman

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 24 3615054; fax: +31 24 3618942.
    • ,
  • I. Jolanda M. de Vries

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Nicole M. Scharenborg

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Annemiek de Boer

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Matthias Broekema

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Wim J.G. Oyen

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Carl G. Figdor

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Gosse J. Adema

      Affiliations

    • Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Otto C. Boerman

      Affiliations

    • Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands

Received 22 December 2005; received in revised form 18 January 2006; accepted 26 February 2006. published online 02 May 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(06)00035-7

doi:10.1016/j.nucmedbio.2006.02.005

Nuclear Medicine and Biology
Volume 33, Issue 4 , Pages 453-458, May 2006

Article Tools

* Image Usage & Resolution